SILO PHARMA, INC. Notes and Loans, Noncurrent
SILO PHARMA, INC. (SILO) had Notes and Loans, Noncurrent of $4.25 thousand as of 2020-12-31, per its 10-K/A filed 2021-05-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes and Loans, Noncurrent
us-gaap:LongTermNotesAndLoans · last filed 2021-05-17
- 2020-12-31: Notes and Loans, Noncurrent $4.25K.
- 2020-09-30: Notes and Loans, Noncurrent $11.64K.
- 2020-06-30: Notes and Loans, Noncurrent $11.64K.
| Period end | Notes and Loans, Noncurrent |
|---|---|
| 2020-12-31 | $4.25K 10-K/A · filed 2021-05-17 |
| 2020-09-30 | $11.64K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.64K 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |